Back to Results
First PageMeta Content
Natural Health Products Directorate / Influenza / Casio / Health / Cold-fX / Drugs / Medicine


Document Date: 2007-03-05 04:55:08

Open Document

File Size: 41,01 KB

Share Result on Facebook

City

Washington / D.C. / /

Company

COLD-fX Pharmaceuticals (USA) Inc. / Investor Relations CV Technologies Inc. / Previous Approval CV Technologies / Dosage / CV Technologies Inc. / Compliance CV Technologies / fX Life Sciences International GmbH / Media Relations CV Technologies Inc. / /

Country

United States / Canada / /

/

IndustryTerm

final product / manufacturing protocol / natural health products / manufacturing / health watchdog / chemical profile / /

MedicalCondition

disease / flu / cold infections / cough / cold/flu / /

MedicalTreatment

dietary supplement / dietary supplements / /

Organization

National Institute of Health / ACNielsen’s MarketTrack Drug Service for Cold Remedies / Natural Supplements & Vitamins Categories / Centre for Science / Natural Health Products Directorate / American Botanical Council / federal government department / Therapeutic Products Directorate of Health Canada / /

Person

Jane Tulloch / Jacqueline Shan / /

/

Position

general economic conditions / President / CEO and Chief Scientific Officer / Director / Vice President / /

PublishedMedium

The Vancouver Sun / the Public Interest / /

Technology

manufacturing protocol / /

URL

www.sedar.com / www.coldfx.com / www.cvtechnologies.com / /

SocialTag